AZYRADA
Dead / Cancelled — Fourth extension request filed (statement of use) (as of 25 Apr 2024)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90739249
- Mark type
- Stylized text
- Filed
- 27 May 2021
- Published for opposition
- 22 Mar 2022
- Attorney of record
- Richard A. Friedman
Goods and services
- Class 005 — Pharmaceuticals: Anti-inflammatory preparations; Pharmaceutical preparations for the treatment of autoimmune diseases, rheumatoid arthritis, plaque psoriasis, Crohn's disease, ulcerative colitis, psoriatic arthritis, ankylosing spondylitis, and juvenile idiopathic arthritis
Owner
- Pfizer Inc., New York, NY, US
- Pfizer Inc., New York, NY, US
Prosecution history
- 26 Apr 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 25 Apr 2024 — SOU EXTENSION 4 GRANTED
- 25 Apr 2024 — SOU EXTENSION 4 FILED
- 25 Apr 2024 — SOU TEAS EXTENSION RECEIVED
- 06 Oct 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Oct 2023 — SOU EXTENSION 3 GRANTED
- 04 Oct 2023 — SOU EXTENSION 3 FILED
- 04 Oct 2023 — SOU TEAS EXTENSION RECEIVED
- 15 Apr 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Apr 2023 — SOU EXTENSION 2 GRANTED
- 13 Apr 2023 — SOU EXTENSION 2 FILED
- 13 Apr 2023 — SOU TEAS EXTENSION RECEIVED
- 28 Mar 2023 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 28 Mar 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 28 Mar 2023 — TEAS CHANGE OF OWNER ADDRESS RECEIVED